- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00173355
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
November 23, 2005 updated by: National Taiwan University Hospital
Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002
Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP) after active invitation
Study Overview
Status
Unknown
Conditions
Detailed Description
Soft tissue sarcoma was rarely seen in pediatric patients, and pediatric Dermatofibrosarcoma Protuberans (PDFSP) was even rare.
To our knowledge, the largest report constituted of 19 cases (five of them had no follow-up (FU) status) (1).
So we proposed this retrospective study based on the cancer registry of our hospital.
Twelve cases who were diagnosed as DFSP before age of 18 were identified.
But all of them had been lost of FU for at least two years.
So we will try to contact these patients and asked them to be back to our clinic for routine surveillance (history taking and physical exam and optional local image/chest xray) and quality of life (QoL) evaluation after pathological review if this clinical study was approved (2)
Study Type
Observational
Enrollment
12
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chun-Ru Chien, M.D.
- Phone Number: 2643 886-2-23123456
- Email: stwo@ha.mc.ntu.edu.tw
Study Contact Backup
- Name: Rong-Sen Yang, M.D, Ph.D
- Phone Number: 3958 886-2-23516478
- Email: yang@ha.mc.ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Rong-Sen Yang, MD, PhD
- Phone Number: 3958 886-23123456
- Email: yang@ha.mc.ntu.edu.tw
-
Contact:
- Chun-Ru Chien, M.D.
- Phone Number: 2643 886-2-23516478
- Email: stwo@ha.mc.ntu.edu.tw
-
Principal Investigator:
- Rong-Sen Yang, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients diagnosed as DFSP before age of 18 after pathological review according to the cancer registry of our hospital
Exclusion Criteria:
- age > 18 at diagnosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Rong-Sen Yang, M.D., Ph.D., National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Completion
August 1, 2005
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 15, 2005
Study Record Updates
Last Update Posted (Estimate)
November 24, 2005
Last Update Submitted That Met QC Criteria
November 23, 2005
Last Verified
August 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9461700618
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Soft Tissue Neoplasms
-
Istituto Ortopedico RizzoliCompletedSoft Tissue Sarcoma | Soft Tissue Neoplasm | Soft Tissue Mass | Soft Tissue LesionItaly
-
Wake Forest University Health SciencesTerminatedSoft Tissue Sarcoma | Soft Tissue Tumor | Soft Tissue Tumor and/or SarcomaUnited States
-
Morristown Medical CenterRecruitingMusculoskeletal Diseases | Soft Tissue MassUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompletedGastric Soft Tissue NeoplasmChina
-
CytRxUnknownUnresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue SarcomaUnited States, Australia, Russian Federation, Hungary, India, Romania, Ukraine
-
University of WashingtonAadi Bioscience, Inc.Active, not recruitingAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue SarcomaUnited States
-
Centre Leon BerardNovartis; National Cancer Institute, FranceRecruitingAdvanced Soft-tissue Sarcoma | Metastatic Soft-tissue SarcomaFrance
-
UNICANCERRecruitingAdvanced Soft-tissue Sarcoma | Metastatic Soft-tissue SarcomaFrance
-
University of Colorado, DenverAgenus Inc.RecruitingAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLCCompletedSoft Tissue Sarcoma, Adult | Soft Tissue Sarcoma, ChildUnited States